Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone.
BACKGROUND
The Rives-Stoppa (RS) repair of ventral incisional hernias (VIHR) is technically difficult. It involves the retromuscular placement of mesh anterior to the posterior fascia and the primary closure of the anterior fascia. Recurrence rates are 0-8%. We proposed that the operation could be done with equal success by placing the mesh in an intraperitoneal position and primarily closing the fascia anterior to the mesh.


METHODS
81 patients who had undergone an open RS-VIHR with intraperitoneal mesh were evaluated for hernia recurrence and factors associated with recurrence.


RESULTS
55 women and 26 men (mean BMI 38+/-9) underwent RS-VIHR (mean age 49+/-11 years). Of these patients, 44 (54%) had a prior VIHR, 30 (37%) had an incarcerated hernia and 34 (42%) had multiple fascial defects. PTFE was used in 83% and Prolene in 12%. Average LOS was 5.8+/-12 days. All received perioperative intravenous antibiotics and 28% were discharged on oral antibiotics. Follow-up averaged 30+/-24 months. Recurrent VIH developed in 12/81 (15%), with three occurring after removal of infected mesh and one after a laparotomy. Excluding these four, the recurrence rate was 10%. There was no correlation between hernia recurrence and age, BMI, hernia size, number of prior repairs, or LOS (t-test p>0.05). Hernia recurrence did not correlate with gender, prior peritoneal contamination, incarceration, multiple defects, adhesions, mesh type, oral antibiotics, cardiac disease, diabetes, tobacco use, or seroma (X(2) p>0.05). Those with a wound infection and/or abscess formation had a significantly higher recurrent hernia rate (60% vs. 8%, X(2) p<0.001). Patients with pulmonary disease had a significantly higher recurrence rate (50% vs. 12%, X(2) p=0.01).


CONCLUSIONS
RS-VIHR with intraperitoneal mesh is a successful and less technically challenging method of repair than prior modifications. Aggressive efforts to identify infection and treat early may prevent abscess formation and subsequent recurrent hernia. Patients with chronic pulmonary disease have an unacceptably high recurrence rate and should not be considered as candidates for elective RS-VIHR.
Heartsill
L
L
Department of Surgery, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA.
Richards
M L
ML
Arfai
N
N
Lee
A
A
Bingener-Casey
J
J
Schwesinger
W H
WH
Sirinek
K R
KR
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006555:Hernia, Ventral / Q000175:diagnosis / Q000601:surgery*; D006801:Humans; D015994:Incidence; D007813:Laparotomy / Q000009:adverse effects / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011126:Polypropylenes; D011183:Postoperative Complications / Q000453:epidemiology*; D011336:Probability; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D013526:Surgical Mesh; D013536:Suture Techniques; D016896:Treatment Outcome; D014945:Wound Healing / Q000502:physiology
D011126:Polypropylenes
Surg Endosc. 2000 Feb;14(2):117-9
10656940
World J Surg. 2000 Jan;24(1):95-100;discussion 101
10594211
Int Surg. 2001 Oct-Dec;86(4):229-34
12056467
Am J Surg. 1999 Jan;177(1):19-22
10037302
Hernia. 2002 Sep;6(3):120-3
12209300
N Engl J Med. 2000 Aug 10;343(6):392-8
10933738
Ann Surg. 2003 Sep;238(3):391-9; discussion 399-400
14501505
Surg Endosc. 2000 May;14(5):419-23
10858463
Surg Gynecol Obstet. 1993 Mar;176(3):228-34
8438193
Surg Endosc. 2000 Dec;14(12):1156-8
11148788
Surg Clin North Am. 1993 Jun;73(3):557-70
8497803
Ann R Coll Surg Engl. 1986 Jul;68(4):185-7
3789602
Br J Surg. 1985 Jan;72(1):70-1
3155634
Surg Gynecol Obstet. 1993 Jan;176(1):18-24
8427001
Surg Endosc. 2000 Jun;14(6):582-4
10890970
Int Surg. 1987 Jan-Mar;72(1):42-4
2954925